Trial intelligence / Profile preview

Blue LED and Metronidazole for Recurrent Bacterial Vaginosis

NCT07835815Not yet recruiting

Start: Sep 2026
Primary completion: Jun 2027

Overview

Randomised, open-label trial in bacterial vaginosis (BV) (2 arms). Primary endpoint: Recurrence of bacterial vaginosis at 3 months. Planned start Sep 2026; status: not yet recruiting.

Conditions

bacterial vaginosis (BV)

Beyond the preview

Go deeper on NCT07835815.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07835815.